EPO Antikörper
Kurzübersicht für EPO Antikörper (ABIN5708355)
Target
Alle EPO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A recombinant mouse protein corresponding to amino acids D34-R192 was used as the immunogen for the Erythropoietin antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the Erythropoietin antibody should be determined by the researcher.\. Western blot: 0.5-1 μg/mL,ELISA: 0.1-0.5 μg/mL (mouse protein tested)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- After reconstitution, the Erythropoietin antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
-
-
- EPO (Erythropoietin (EPO))
-
Andere Bezeichnung
- Erythropoietin
-
Substanzklasse
- Hormone
-
Hintergrund
- The EPO gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies.
-
UniProt
- P01588
-
Pathways
- JAK-STAT Signalweg, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-